A phase II/III randomized, multicenter trial of prednisone/sirolimus <i>versus</i> prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-<i>versus</i>-host disease: BMT CTN 0801
Paul A. Carpenter(Fred Hutch Cancer Center), Mukta Arora(Fairview Health Services), Aleksandr Lazaryan(Moffitt Cancer Center), Edmund K. Waller(Emory University), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Corey Cutler(Harvard University), Stephanie J. Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Amin M. Alousi(McGill University), Eneida R. Nemecek(Oregon Health & Science University), Laura Johnston(Stanford Medicine), Jiaxi Zhu(Emmes (United States)), Adam Mendizabal(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Steven Z. Pavletic(National Institutes of Health), Carrie L. Kitko(Vanderbilt University Medical Center), Daniel J. Weisdorf(University of Minnesota), Stefanie Sarantopoulos(Duke University), Sunil Abhyankar(University of Kansas Medical Center), Mary M. Horowitz(Medical College of Wisconsin), Juan Wu(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Javier Bolaños‐Meade(Johns Hopkins University), Kelly O’Brien(Emmes (United States)), Luciano J. Costa(University of Alabama at Birmingham)
Cited by 55
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
|Journal of Clinical Oncology|2006|2k